SKI Market

A+| A| A-|

Indian Indices

Sensex

78,151.45 964.58
( 1.25%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Biocon Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532523

INE376G01013

168.1885009

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BIOCON

299.32

71217.63

EPS(TTM)

Face Value()

Div & Yield %

1.46

0.11

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	2346.40	2242.60	2127.30	1992.90	1738.20	2028.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2346.40	2242.60	2127.30	1992.90	1738.20	2028.40
Other Income	319.70	849.80	207.50	3134.20	187.20	150.20
Stock Adjustments	118.70	54.60	99.10	-3.20	105.80	-36.70
Total Income	2784.80	3147.00	2433.90	5123.90	2031.20	2141.90
EXPENDITURE :
Raw Materials	1187.60	1085.40	1033.80	981.00	914.00	761.60
Power & Fuel Cost	215.80	192.00	215.30	279.20	231.00	186.00
Employee Cost	467.20	501.30	452.30	433.80	367.70	390.20
Other Manufacturing Expenses	165.90	150.70	155.40	127.10	130.50	147.00
Selling & Administrative Expenses	193.20	172.00	135.00	112.20	106.70	128.40
Miscellaneous Expenses	224.40	20.00	-28.10	32.90	33.00	66.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	2454.10	2121.40	1963.70	1966.20	1782.90	1679.20
Operating Profit	330.70	1025.60	470.20	3157.70	248.30	462.70
Interest	142.40	236.90	198.80	69.60	0.40	0.40
Gross Profit	188.30	788.70	271.40	3088.10	247.90	462.30
Depreciation	137.30	127.80	121.10	116.90	108.20	103.50
Profit Before Tax	51.00	660.90	150.30	2971.20	139.70	358.80
Tax	12.00	30.60	15.10	132.70	60.70	73.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.80	21.00	15.90	-9.90	-7.10	4.80
Reported Net Profit	37.20	609.30	119.30	2848.40	86.10	280.50
Extraordinary Items	-138.10	660.11	13.41	2861.73	2.92	3.00
Adjusted Net Profit	175.30	-50.81	105.89	-13.33	83.18	277.50
Adjustment below Net Profit	-23.50	-1.30	30.70	29.40	-59.40	30.40
P & L Balance brought forward	10468.50	9920.50	9950.60	7132.80	7106.10	6795.20
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	66.80	60.00	180.10	60.00	0.00	0.00
P & L Balance carried down	10415.40	10468.50	9920.50	9950.60	7132.80	7106.10
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	30.00	10.00	0.00
Dividend Per Share(Rs)	0.50	0.50	0.50	1.50	0.50	0.00
Earnings Per Share-Unit Curr	0.23	5.07	0.99	23.72	0.72	2.34
Earnings Per Share(Adj)-Unit Curr	0.23	5.07	0.99	23.72	0.72	2.34
Book Value-Unit Curr	166.85	96.63	90.88	90.91	67.40	65.88
Book Value(Adj)-Unit Curr	166.85	96.63	90.88	90.91	67.40	65.88

78,151.45 964.58 ( 1.25%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)